Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

August 2027 82

  1. Primary completion A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07394114

  2. Study completion Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04499859

  3. Primary completion Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05892510

  4. Study completion New Interactive Sensor-home-based Hand Training to Improve Dexterity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06062693

  5. Primary completion New Interactive Sensor-home-based Hand Training to Improve Dexterity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06062693

  6. Study completion Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06733246

  7. Primary completion Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07290699

  8. Primary completion A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07417306

  9. Study completion Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07508618

  10. Primary completion Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07508618

  11. Study completion Low-Dose Pioglitazone in Patients With NASH (AIM 2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04501406

  12. Primary completion Low-Dose Pioglitazone in Patients With NASH (AIM 2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04501406

  13. Study completion The Arteriovenous Vascular (AV) ACCESS Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04646226

  14. Study completion Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04924322

  15. Study completion The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04981327

  16. Study completion Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05164263

  17. Study completion The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05464095

  18. Primary completion Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06241261

  19. Primary completion High-definition Transcranial Electrical Stimulation for Upper Extremity Rehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06409143

  20. Study completion SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06590012

  21. Study completion Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06775782

  22. Study completion A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06845202

  23. Primary completion A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06845202

  24. Study completion Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07249853

  25. Primary completion Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07252544

  26. Primary completion Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07324031

  27. Study completion ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07484009

  28. Primary completion Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07759427

September 2027 126

  1. Study start Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00117936

  2. Primary completion Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03821623

  3. Study completion accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03863132

  4. Primary completion accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03863132

  5. Study completion Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04505618

  6. Primary completion Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05268094

  7. Study completion Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05476991

  8. Primary completion Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05476991

  9. Primary completion Pulmonary Artery Catheter in Cardiogenic Shock Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05485376

  10. Primary completion Polypill for Prevention of Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06143566

  11. Study completion VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06384599

  12. Study completion Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06466161

  13. Study completion MAX - SHOCK Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06556667

  14. Primary completion MAX - SHOCK Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06556667

  15. Study completion Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06744361

  16. Primary completion Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06744361

  17. Study completion Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06855537

  18. Primary completion Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06855537

  19. Study completion Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946589

  20. Primary completion Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06968806

  21. Primary completion Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07180472

  22. Primary completion Butylphthalide for Long-term Efficacy in Minor Stroke Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07230587

  23. Primary completion Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07247864

  24. Study completion Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07263035

  25. Primary completion Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07337577

  26. Study completion Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07776054

  27. Study start Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07797036

  28. Study completion A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07872436

  29. Study completion The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07897409

  30. Study completion IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04221815

  31. Study completion Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04602754

  32. Study completion Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04634916

  33. Study completion Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04748796

  34. Study completion Valveclip® Transcatheter Mitral Valve Repair Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05021614

  35. Study completion Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05028140

  36. Study completion Serotonin Receptor Blockers in Ischemic Mitral Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05469165

  37. Primary completion Improving CRT Outcome With Non-Invasive Cardiac Mapping Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05564793

  38. Primary completion Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691244

  39. Study completion Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05769868

  40. Primary completion The Danish Out-of-Hospital Cardiac Arrest Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05895838

  41. Primary completion SELUTION 4 De Novo Small Vessel IDE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05946629

  42. Study completion Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029491

  43. Primary completion Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078436

  44. Study completion Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06226805

  45. Study completion Modafinil and Exercise for Post Stroke Fatigue Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06354985

  46. Primary completion Modafinil and Exercise for Post Stroke Fatigue Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06354985

  47. Primary completion NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06511505

  48. Study completion Abbott Medical - VERITAS Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06707688

  49. Primary completion Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06736574

  50. Primary completion Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06779630

  51. Primary completion A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06843577

  52. Study completion Randomised EValuation of Therapies for microvAscuLar Injury in STEACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06935383

  53. Primary completion Randomised EValuation of Therapies for microvAscuLar Injury in STEACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06935383

  54. Study completion A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06948422

  55. Primary completion A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06948422

  56. Study completion A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06948435

  57. Primary completion A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06948435

  58. Study completion A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06952530

  59. Primary completion A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06952530

  60. Study completion Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07017270

  61. Study completion BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181590

  62. Primary completion BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181590

  63. Study completion Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07308184

  64. Primary completion Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414342

  65. Primary completion WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523269

  66. Study completion Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07571447

  67. Primary completion Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07571447

  68. Primary completion Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687212

  69. Primary completion Capital Offload-Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07756801

  70. Study completion Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07781462

  71. Primary completion Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07781462

  72. Primary completion Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07890740

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO) Registry record

    Expected 2020-02; that period ended on 2020-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01550588

  2. Primary completion Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO) Registry record

    Expected 2020-02; that period ended on 2020-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01550588

  3. Study start Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery Registry record

    Expected 2020-02; that period ended on 2020-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04284722

  4. Study completion Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies Registry record

    Expected 2020-03-01; that period ended on 2020-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03578848

  5. Study start Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents Registry record

    Expected 2020-03-02; that period ended on 2020-03-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04287387

  6. Primary completion Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. Registry record

    Expected 2020-03-08; that period ended on 2020-03-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03501680

  7. Study completion Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement Registry record

    Expected 2020-03-15; that period ended on 2020-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03440268

  8. Study completion Intracranial Thrombosis Aspiration Catheter for Recanalization in Acute Ischemic Stroke Therapy (RECOVER) Registry record

    Expected 2020-03-20; that period ended on 2020-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753061

  9. Primary completion Intracranial Thrombosis Aspiration Catheter for Recanalization in Acute Ischemic Stroke Therapy (RECOVER) Registry record

    Expected 2020-03-20; that period ended on 2020-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753061

  10. Study completion THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS) Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02002325

  11. Primary completion Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02317458

  12. Study completion Once-daily Fixed Combination of Three Antihypertensive Drugs Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02710539

  13. Study completion Low-dose Combination of Three Antihypertensive Drugs Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02710552

  14. Primary completion CTEPH DIAGNOSIS Europe - MRI Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02791282

  15. Study completion In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02892903

  16. Primary completion Prognostic Predictors of Response to Hypoglycemic Therapy Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03804411

  17. Study completion Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery Registry record

    Expected 2020-03-31; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03838328

  18. Study completion Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy Registry record

    Expected 2020-03-31; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03874260

  19. Study completion Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03965975

  20. Primary completion Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03965975

  21. Primary completion Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2020-03; that period ended on 2020-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04014023

  22. Study start Effect of Atorvastatin on Carotid Intima Media Thickness Registry record

    Expected 2020-04-15; that period ended on 2020-04-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04306627

  23. Study completion High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting Registry record

    Expected 2020-04-30; that period ended on 2020-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03079115

  24. Primary completion High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting Registry record

    Expected 2020-04-30; that period ended on 2020-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03079115

  25. Study completion Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD Registry record

    Expected 2020-04-30; that period ended on 2020-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03150667

  26. Study completion A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy Registry record

    Expected 2020-04-30; that period ended on 2020-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03834207

  27. Study start Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Registry record

    Expected 2020-04-30; that period ended on 2020-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04349683

  28. Study completion Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT Registry record

    Expected 2020-05-01; that period ended on 2020-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03112707

  29. Primary completion Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT Registry record

    Expected 2020-05-01; that period ended on 2020-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03112707

  30. Study completion Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion Registry record

    Expected 2020-05-01; that period ended on 2020-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04091412

  31. Study start Early Treatment of ARNI on Myocardial Remodeling and Progress Registry record

    Expected 2020-05-01; that period ended on 2020-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04342351

  32. Study completion Effect of CPAP in the Worsening of Renal Function in Early Stages of Chronic Kidney Disease (CKD) Registry record

    Expected 2020-05-20; that period ended on 2020-05-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03319888

  33. Study completion Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement Registry record

    Expected 2020-05-30; that period ended on 2020-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03965065

  34. Primary completion Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement Registry record

    Expected 2020-05-30; that period ended on 2020-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03965065

  35. Study completion A Prospective Randomized Multicenter Trial of the Guidewire for Echo-guided Interventions Registry record

    Expected 2020-05-30; that period ended on 2020-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04096924

  36. Study completion First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01960504

  37. Study completion Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02967484

  38. Primary completion Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02967484

  39. Study completion Prognostic Predictors of Response to Hypoglycemic Therapy Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03804411

  40. Primary completion Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03987321

  41. Study start Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04074408

  42. Study start Evaluating a Digital Diabetes Education Program Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04198935

  43. Study start Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04277702

  44. Study completion Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04390295

  45. Primary completion Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes Registry record

    Expected 2020-05; that period ended on 2020-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04390295

  46. Study completion Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients Registry record

    Expected 2020-06-01; that period ended on 2020-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03271879

  47. Primary completion Ivabradine to Prevent Anthracycline-induced Cardiotoxicity Registry record

    Expected 2020-06-01; that period ended on 2020-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04030546

  48. Study start Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices. Registry record

    Expected 2020-06-01; that period ended on 2020-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04303793

  49. Study completion Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial Registry record

    Expected 2020-06-17; that period ended on 2020-06-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03980990

  50. Primary completion Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial Registry record

    Expected 2020-06-17; that period ended on 2020-06-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03980990

  51. Primary completion Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose Registry record

    Expected 2020-06-29; that period ended on 2020-06-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04460092

  52. Study completion Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01764334

  53. Study completion Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02216058

  54. Primary completion Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02224131

  55. Study completion NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02305485

  56. Primary completion Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02449330

  57. Study completion PeRiodontal Treatment to Eliminate Minority InEquality and Rural Disparities in Stroke Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02541032

  58. Study completion CTEPH DIAGNOSIS Europe - MRI Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02791282

  59. Primary completion Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02798913

  60. Primary completion A Study of Below The Knee Arteries' Stenosis or Occlusion Treated With LEGFLOW OTW Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02962232

  61. Primary completion Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03044184

  62. Primary completion A Trial Testing Amiodarone in Chagas Cardiomiopathy Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03193749

  63. Primary completion TEC4Home Heart Failure: Using Home Health Monitoring to Support the Transition of Care Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03439384

  64. Primary completion Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03511313

  65. Study completion Dabigatran Versus Warfarin With NVAF Who Undergo PCI Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03536611

  66. Study completion BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03548272

  67. Primary completion Trial for MicroPort's Firesorb BVS: FUTURE-III Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03660202

  68. Primary completion Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH) Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03844594

  69. Primary completion Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03986073

  70. Study completion Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03987321

  71. Study start Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03993730

  72. Study completion Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04014023

  73. Primary completion Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04023565

  74. Study completion Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04034966

  75. Study start Intraosseous Versus Intravenous Vascular Access During Resuscitation Following Out-of-Hospital Cardiac Arrest Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04130984

  76. Study start CRT-P or CRT-D in Dilated Cardiomyopathy Registry record

    Expected 2020-06; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04139460

  77. Study start A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04255238

  78. Study completion Far Infrared Therapy on Peritoneal Function of CAPD Patients Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04344067

  79. Primary completion Far Infrared Therapy on Peritoneal Function of CAPD Patients Registry record

    Expected 2020-06-30; that period ended on 2020-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04344067

  80. Study completion Heart Monitoring Device After Acute Myocardium Infarction Registry record

    Expected 2020-07-01; that period ended on 2020-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03494751

  81. Study completion Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety Registry record

    Expected 2020-07-01; that period ended on 2020-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03667677

  82. Primary completion Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis Registry record

    Expected 2020-07-02; that period ended on 2020-07-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04462003

  83. Study completion Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis Registry record

    Expected 2020-07-03; that period ended on 2020-07-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04462003

  84. Primary completion Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction Registry record

    Expected 2020-07-14; that period ended on 2020-07-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03882775

  85. Study start Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia Registry record

    Expected 2020-07-15; that period ended on 2020-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04438096

  86. Primary completion Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. Registry record

    Expected 2020-07-30; that period ended on 2020-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04046029

  87. Primary completion Feasibility Study of the Intravascular Ventricular Assist System (iVAS) Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02645539

  88. Study completion Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02738749

  89. Primary completion Proton Radiotherapy for Primary Central Nervous System Tumours in Adults Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02797366

  90. Study completion Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02798913

  91. Study completion Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02948998

  92. Primary completion Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03121430

  93. Study completion Local Paclitaxel or Balloon Angioplasty Below the Knee Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03149913

  94. Primary completion Neuroprotectant for Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2020-07-31; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03546283

  95. Primary completion Evaluating a Digital Diabetes Education Program Registry record

    Expected 2020-07; that period ended on 2020-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04198935

  96. Study start Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke Registry record

    Expected 2020-08-01; that period ended on 2020-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03045055

  97. Study completion Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence Registry record

    Expected 2020-08-01; that period ended on 2020-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03592823

  98. Primary completion Evaluation of the Detection of Atrial Fibrillation by a Wearable Dynamic ECG Recorder Registry record

    Expected 2020-08-01; that period ended on 2020-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04462653

  99. Study completion Effect of Vasopressin, Steroid, and Epinephrine Treatment in Patients With Out-of-hospital Cardiac Arrest Registry record

    Expected 2020-08-09; that period ended on 2020-08-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03317197

  100. Primary completion Effect of Vasopressin, Steroid, and Epinephrine Treatment in Patients With Out-of-hospital Cardiac Arrest Registry record

    Expected 2020-08-09; that period ended on 2020-08-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03317197